Research Topics
Genomes and Genes | Rolf I SkotheimSummaryAffiliation: Institute for Cancer Research Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen
Medical Biotechnology, VTT Technical Research Centre and University of Turku, Itäinen Pitkäkatu 4C, Turku, Finland
Genome Biol 9:R139. 2008..This database of gene expression patterns in normal human tissues and pathological conditions covers 113 million datapoints and is available from the GeneSapiens website...
A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysisRolf I Skotheim
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
Mol Cancer 8:5. 2009..However, the available methodologies to detect such fusions all have their distinct short-comings...
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survivalAnita Sveen
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953 Nydalen, NO 0424 Oslo, Norway
Genome Med 3:32. 2011..In the present study we analyze genome-wide disruption of pre-mRNA splicing, and propose transcriptome instability as a characteristic that is analogous to genomic instability on the transcriptome level...
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal developmentRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Norway
Cancer Res 65:5588-98. 2005....
Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changesRolf I Skotheim
Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
Cell Oncol 28:315-26. 2006..Testicular germ cell tumors of adolescent and young adult men (TGCTs) generally have near triploid and complex karyotypes. The actual genes driving the tumorigenesis remain essentially to be identified...
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markersTerje Ahlquist
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
Mol Cancer 7:94. 2008..Possible CIMP tumors were identified by comparing the methylation profile with microsatellite instability (MSI), BRAF-, KRAS-, and TP53 mutation status...
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylationGuro E Lind
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
Mol Cancer 4:8. 2005..However, other epigenetic mechanisms, such as modulation of chromatin structure or modifications of histones, may explain the lack of NKX3.1 expression, which is seen in most TGCTs and prostate cancer specimens...
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient groupHelge R Brekke
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet, Oslo University Hospital, Oslo, Norway
J Clin Oncol 28:1573-82. 2010..The purpose of this study was to identify genetic aberrations contributing to clinical aggressiveness of malignant peripheral nerve sheath tumors (MPNSTs)...
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genesFrancesca Micci
Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway
Genes Chromosomes Cancer 49:1046-53. 2010....
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomasGuro E Lind
Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
Mol Cancer 10:85. 2011..This study investigates a panel of epigenetic markers for the detection of colorectal cancer and adenomas...
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Norway
J Clin Oncol 21:4586-91. 2003..This study is the first to suggest that TOP2A expression may be a predictive factor for adverse outcome in MPNST...
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosisTrude H Agesen
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Nydalen, Oslo, Norway
Gut 61:1560-7. 2012..The present study aimed to develop a gene expression classifier for improved risk stratification of patients with stage II CRC...
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility lociMarianne Berg
Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
Mol Cancer 9:100. 2010..Integration analysis of CNV and genome wide mRNA expression data, available for the same tumors, was performed to identify a restricted candidate gene list...
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptomeStine A Danielsen
Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
PLoS ONE 6:e24419. 2011..In conclusion, we have identified significantly deregulated pathways in CRC, and validated repression of PLCD1 and PLCE1 expression. This illustrates that the GSEA approach may guide discovery of novel biomarkers in cancer...
Hypermethylated MAL gene - a silent marker of early colon tumorigenesisGuro E Lind
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
J Transl Med 6:13. 2008..The aim of the present study was to investigate the potential of the MAL (T-cell differentiation protein) gene as an early epigenetic diagnostic marker for colorectal tumors...
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancerAnita Sveen
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Int J Cancer 131:1479-85. 2012..In conclusion, the SLC39A14-exon4B transcript variant is a CRC biomarker with high sensitivity and organ-confined specificity. Further use of the transcript and its encoded protein isoform should be explored in an organ-confined context...
Fusion gene microarray reveals cancer type-specificity among fusion genesMarthe Løvf
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Genes Chromosomes Cancer 50:348-57. 2011..We therefore find it unlikely that the assayed fusion genes are commonly present across multiple cancer types...
The epigenome of testicular germ cell tumorsGuro E Lind
Department of Cancer Prevention, Rikshospitalet Radiumhospitalet Medical Centre, Montebello and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway
APMIS 115:1147-60. 2007..Aberrant DNA methylation has the potential to improve current diagnostics by noninvasive testing and might also serve as a prognostic marker for treatment response...
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarraysRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Neoplasia 5:397-404. 2003..In summary, we have developed a high-throughput tool for the evaluation of TGCT markers, and utilized this to validate five candidate genes whose protein expressions were indeed deregulated in TGCT...
ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patientsAnita Sveen
Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Clin Cancer Res 18:6001-10. 2012..This study was conducted to develop a clinically feasible and robust prognostic classifier for these patients independent of adjuvant treatment...
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancerLina Cekaite
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Neoplasia 14:868-79. 2012..This study suggests that deregulated expression of miR-9, miR-31, and miR-182 during carcinogenesis plays a significant role in the development of colon cancer by promoting proliferation and tumor cell survival...
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatosesKristine Kleivi
Department of Genetics, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
Mol Cancer 6:2. 2007..Therefore, the aim of the present study is to investigate and compare the gene expression patterns of primary carcinomas (n = 18), liver metastases (n = 4), and carcinomatoses (n = 4), relative to normal samples from the large bowel...
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsHelge R Brekke
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Neuro Oncol 11:514-28. 2009..Patients in complete remission with a primary p53-positive MPNST diagnosis may be considered in a high-risk subgroup and candidates for adjuvant treatment...
TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumoursSharmini Alagaratnam
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet HE, Oslo, Norway
Mol Cell Endocrinol 306:75-80. 2009..TPD52 was expressed in two-thirds of seminomas and embryonal carcinomas, and at intermediate frequencies in the more differentiated non-seminomas...
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancerPaula Paulo
Department of Genetics, Portuguese Oncology Institute, Porto, Portugal
Genes Chromosomes Cancer 51:240-9. 2012..015). We report that FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer and that intratumor genetic heterogeneity of ETS rearrangements can occasionally be found in index primary tumors...
NKX3.1 expression is lost in testicular germ cell tumorsRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Oslo, Norway
Am J Pathol 163:2149-54. 2003..These results suggest that NKX3.1 is essential for normal testis function and that its loss of expression is highly associated with the invasive phenotype of testicular germ cell tumors...
Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumorsSigrid M Kraggerud
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310, Oslo, Norway
Cancer Genet Cytogenet 147:1-8. 2003..In summary, our results support the theory that a nonimprinted 11p15 tumor suppressor gene is involved in the development of a subgroup of TGCTs...
The testicular germ cell tumour genomeRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway
APMIS 111:136-50; discussion 50-1. 2003....
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement mapFrancesca Micci
Department of Medical Genetics, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Genes Chromosomes Cancer 48:184-93. 2009..A detailed map of the rearrangements should provide clues to the positions of oncogenes and potential fusion genes important in ovarian carcinogenesis...
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genesRicardo Celestino
Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Genes Chromosomes Cancer 51:1154-64. 2012..Our results reinforce the pathogenic role played by RET/PTC1, RET/PTC3, and PAX8-PPARG fusion genes in thyroid tumorigenesis...
Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcomaKaja B Nyquist
Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
PLoS ONE 7:e49705. 2012..This demonstrates that genetic heterogeneity exists in mesenchymal chondrosarcoma...
Genome profiles of familial/bilateral and sporadic testicular germ cell tumorsSigrid Marie Kraggerud
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Genes Chromosomes Cancer 34:168-74. 2002..02, respectively), whereas gain of the proximal 17q (17q11.2-21) and high-level amplification from chromosome arm 12p, and losses from 10q were associated with nonseminomas (P < 0.001, P = 0.04, and P = 0.03, respectively)...
A tumor-associated mutation of FYVE-CENT prevents its interaction with Beclin 1 and interferes with cytokinesisAntonia P Sagona
Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
PLoS ONE 6:e17086. 2011..These findings suggest a positive feedback loop for recruitment of FYVE-CENT and Beclin 1 to the intercellular bridge during cytokinesis, and reveal a novel potential tumor suppressor mechanism for Beclin 1...
Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumorsEspen Burum-Auensen
Division of Pathology, Medical Faculty, University of Oslo, Rikshospitalet, Oslo University Hospital, Oslo, Norway
J Carcinog 9:1. 2010..The importance of these spindle proteins remains unknown in the development of TGCTs, thus we have explored the expression levels of these proteins in normal and malignant testicular tissues...
Alternative splicing in cancer: noise, functional, or systematic?Rolf I Skotheim
Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
Int J Biochem Cell Biol 39:1432-49. 2007..These studies are expected to open an entirely new level of genetic information that is currently still poorly understood...
New insights into testicular germ cell tumorigenesis from gene expression profilingRolf I Skotheim
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N 0310 Oslo, Norway
Cancer Res 62:2359-64. 2002....
